Traws Pharma Profit Margin

Traws Pharma (TRAW) currently reports a profit margin of -71375.16% as of May 2026. That compares with -73682.74% in the prior-year period — up 3.1% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Traws Pharma's profit margin history and peer comparisons.

Traws Pharma's profit margin increased from -73682.74% to -71375.16% — a 3.1% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Traws Pharma's profit margin of -71375.16% is lower than the Healthcare sector average of 19.13%. That is roughly 373180.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Traws Pharma's current -71375.16% should be judged against Healthcare norms (sector average: 19.13%) and against TRAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -71375.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Traws Pharma, and consider following TRAW for alerts when major investors trade the stock.